Diazoxide
- 3 June 1976
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 294 (23) , 1271-1274
- https://doi.org/10.1056/nejm197606032942306
Abstract
DIAZOXIDE, a benzothiadiazine derivative closely related chemically to the thiazide diuretics (Fig. 1), lacks the 7-sulfonamide group and a halogen substitution at the 6 position, does not inhibit carbonic anhydrase, and is devoid of chloriuretic and natriuretic activity. It is a potent and rapidly acting antihypertensive agent and, after 12 years of clinical trial, was marketed three years ago for intravenous therapy of hypertensive emergencies.Mechanism of ActionDiazoxide exerts its hypotensive action entirely by reducing vascular resistance in all circulatory beds through direct relaxation of arteriolar smooth muscle.1 2 3 4 5 6 The cellular mechanism of this effect is not yet understood; it . . .This publication has 39 references indexed in Scilit:
- Vasodilator Drugs in the Treatment of HypertensionArchives of internal medicine (1960), 1974
- Myocardial inactivity of therapeutic concentrations of hydralazine and diazoxideCellular and Molecular Life Sciences, 1974
- Hemodynamic comparison of agents useful in hypertensive emergenciesAmerican Heart Journal, 1973
- The effect of diazoxide on the veinsAmerican Heart Journal, 1972
- Action of Diazoxide on Skeletal Muscle Vascular ResistanceCirculation Research, 1971
- Some effects of the hypotensive drug diazoxide on the cardiovascular systemAmerican Heart Journal, 1968
- Intravenous Use of Diazoxide in the Treatment of Severe HypertensionCirculation, 1968
- DIAZOXIDE THERAPY IN HYPERTENSIONThe Lancet Healthy Longevity, 1963
- Clinical Evaluation of DiazoxideCirculation, 1963
- The Acute Hemodynamic Effects of Diazoxide in ManCirculation, 1963